Mouna Zghal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mouna Zghal has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Marwa Bouhamed
Department of Pathology and Research Laboratory LR18SP10, Habib Bourguiba University Hospital, University Hospital, University of Sfax, Sfax, Tunisia
4 shared publicationsSaadia Makni
Department of Pathology and Research Laboratory LR18SP10, Habib Bourguiba University Hospital, University Hospital, University of Sfax, Sfax, Tunisia
4 shared publicationsTahya Boudawara
Department of Pathology and Research Laboratory LR18SP10, Habib Bourguiba University Hospital, University of Sfax, Sfax, Tunisia
4 shared publicationsLobna Ayedi
Pathology Department and Research Laboratory LR18SP10, Habib Bourguiba University Hospital, Sfax
3 shared publicationsManel Mellouli
Habib Bourguiba University Hospital, University of Sfax Tunisia
3 shared publicationsMeriam Triki
Habib Bourguiba University Hospital, University of Sfax Tunisia
3 shared publications
Latest Publications
- Open Access
- 8 May 2026
- Published by Galenos Yayinevi in Turkish Journal of Surgery
- Vol. 42 (2) , 196-206
Predictive factors of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: A single-center study
Predictive factors of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: A single-center study - Turkish Journal of Surgery
- 8 May 2026
- Published by Galenos Yayinevi in Turkish Journal of Surgery
- Vol. 42 (2) , 196-206
Open AccessPredictive factors of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: A single-center study
Predictive factors of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: A single-center study - Turkish Journal of Surgery
- 6 January 2026
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 42 (3) , 432-434
Localized nodular pulmonary amyloidosis: an uncommon diagnosis with malignancy-like features
An 83-year-old woman presented with a nodule in the upper lobe of her left lung, discovered incidentally on a standard chest X-ray. Chest computed tomography (CT) revealed a peripheral, subpleural nodule with spiculated margins and some calcifications, features highly suggestive of malignancy. A wedge resection of the nodule was performed. Macroscopically, the surgical specimen consisted of a firm, grayish subpleural nodule measuring 6 cm in greatest diameter. Histologically, the lung tissue was replaced by an amorphous eosinophilic acellular deposit that stained brick red with Congo red and exhibited an apple-green birefringence under polarized light. This appearance was consistent with an amyloid deposit. No associated neoplastic lesion was identified. A comprehensive clinical work-up was undertaken to exclude systemic amyloidosis, which yielded negative results. Consequently, a diagnosis of localized nodular pulmonary amyloidosis (NPA) was established. NPA is an exceedingly rare entity, often discovered incidentally, and manifests as a single or multiple subpleural nodules of varying sizes. The radiological appearance is non-specific, leading to misdiagnosis of pulmonary cancer. The definitive diagnosis is made by histopathological examination. Therefore, localized NPA should be considered in the differential diagnosis of a pulmonary nodule. Awareness of this rare condition is crucial to avoid misdiagnosis and unnecessary extensive surgical procedures.
- 6 January 2026
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 42 (3) , 432-434
Localized nodular pulmonary amyloidosis: an uncommon diagnosis with malignancy-like features
An 83-year-old woman presented with a nodule in the upper lobe of her left lung, discovered incidentally on a standard chest X-ray. Chest computed tomography (CT) revealed a peripheral, subpleural nodule with spiculated margins and some calcifications, features highly suggestive of malignancy. A wedge resection of the nodule was performed. Macroscopically, the surgical specimen consisted of a firm, grayish subpleural nodule measuring 6 cm in greatest diameter. Histologically, the lung tissue was replaced by an amorphous eosinophilic acellular deposit that stained brick red with Congo red and exhibited an apple-green birefringence under polarized light. This appearance was consistent with an amyloid deposit. No associated neoplastic lesion was identified. A comprehensive clinical work-up was undertaken to exclude systemic amyloidosis, which yielded negative results. Consequently, a diagnosis of localized nodular pulmonary amyloidosis (NPA) was established. NPA is an exceedingly rare entity, often discovered incidentally, and manifests as a single or multiple subpleural nodules of varying sizes. The radiological appearance is non-specific, leading to misdiagnosis of pulmonary cancer. The definitive diagnosis is made by histopathological examination. Therefore, localized NPA should be considered in the differential diagnosis of a pulmonary nodule. Awareness of this rare condition is crucial to avoid misdiagnosis and unnecessary extensive surgical procedures.
- Open Access
- 29 December 2025
- Published by Romodanov Neurosurgery Institute in Ukrainian Neurosurgical Journal
- Vol. 31 (4) , 61-67
Status and prognostic impact of IDH1 in adult grade 4 diffuse gliomas
Background and objectives: The fifth edition of the WHO Classification of Tumors of the Central Nervous System divides grade 4 diffuse glioma based on IDH1 mutation in grade 4 astrocytoma, IDH-mutant and glioblastoma, IDH-wild type tumors. This study aimed to evaluate the IDH1 status in grade 4 diffuse glioma as well as its correlation with clinicopathological features and patient survival. To our knowledge, no Tunisian studies on the molecular profile of diffuse glioma have yet been published. Methods: This is a retrospective study including all cases of adult, grade 4 diffuse glioma collected in the pathology department of Habib Bourguiba hospital. Results: A total of 67 patients were included in the final analysis. The expression of IDH1 was positive in 22 cases (32%). IDH1-positive tumors were classified as grade 4 astrocytoma, IDH1-mutant while, 45 IDH1-negative tumors were classified as glioblastoma, IDH1-wild type tumors (68%). IDH1 expression was correlated with younger age (≤ 40 years old), frontal location, complete surgical resection and well-defined borders. IDH1-positive tumors were associated significantly with better prognosis. The 1-year overall survival (OS) for grade 4 astrocytoma, IDH1-mutant was 86% compared with 8% in glioblastoma, IDH1-wild type (p=0.008). Conclusion: Our study investigated IDH1 expression in grade 4 diffuse glioma and proved that grade 4 astrocytoma, IDH1 positive tumors displayed different characteristics with a more favorable outcome compared to glioblastoma, IDH1 negative. Thus, evaluation of IDH1 mutation should be standardized routinely not only as diagnostic marker but also to refine the prognostic classification of these tumors.
- 29 December 2025
- Published by Romodanov Neurosurgery Institute in Ukrainian Neurosurgical Journal
- Vol. 31 (4) , 61-67
Open AccessStatus and prognostic impact of IDH1 in adult grade 4 diffuse gliomas
Background and objectives: The fifth edition of the WHO Classification of Tumors of the Central Nervous System divides grade 4 diffuse glioma based on IDH1 mutation in grade 4 astrocytoma, IDH-mutant and glioblastoma, IDH-wild type tumors. This study aimed to evaluate the IDH1 status in grade 4 diffuse glioma as well as its correlation with clinicopathological features and patient survival. To our knowledge, no Tunisian studies on the molecular profile of diffuse glioma have yet been published. Methods: This is a retrospective study including all cases of adult, grade 4 diffuse glioma collected in the pathology department of Habib Bourguiba hospital. Results: A total of 67 patients were included in the final analysis. The expression of IDH1 was positive in 22 cases (32%). IDH1-positive tumors were classified as grade 4 astrocytoma, IDH1-mutant while, 45 IDH1-negative tumors were classified as glioblastoma, IDH1-wild type tumors (68%). IDH1 expression was correlated with younger age (≤ 40 years old), frontal location, complete surgical resection and well-defined borders. IDH1-positive tumors were associated significantly with better prognosis. The 1-year overall survival (OS) for grade 4 astrocytoma, IDH1-mutant was 86% compared with 8% in glioblastoma, IDH1-wild type (p=0.008). Conclusion: Our study investigated IDH1 expression in grade 4 diffuse glioma and proved that grade 4 astrocytoma, IDH1 positive tumors displayed different characteristics with a more favorable outcome compared to glioblastoma, IDH1 negative. Thus, evaluation of IDH1 mutation should be standardized routinely not only as diagnostic marker but also to refine the prognostic classification of these tumors.
- 1 June 2024
- Published by Universa BV in Acta Orthopaedica Belgica
- Vol. 90 (2) , 303-309
Epidemiology of bone tumors in children and adolescents: a retrospective study of 266 patients in the south of Tunisia
Although bone tumors (BT) are relatively uncommon among the human neoplasm, they constitute the most frequent tumors in children and adolescents (CAA). Little information is available about the epidemiologic features of BT in CAA. We aimed to present and discuss epidemiological characteristics of BT in CAA in southern Tunisia, regarding the different histological types. This is a retrospective study including cases of BT in CAA collected in the pathology department at the Habib Bourguiba university hospital over a period of 15 years (2006- 2020). A total of 266 BT was diagnosed in our institution (42,7% among all BT in Southern Tunisia) divided into 200 benign bone tumors (BBT) (75,2%) and 66 malignant bone tumors (MBT) (24,8%). The mean age for all BT was 14,2 years (3-20 years) with male predominance (sex ratio: 1,48). The most common tumor was osteochondroma (42.2%) followed by osteosarcoma (14.6%) and Ewing sarcoma (6.4%). For BBT, the most affected age group was the 16 to 20 year - old - group (50,7%) with a male predominance (59.8%) and a predilection for lower limb (66.8%) then the upper limb (16,8%). Osteochondroma was the most common histological type (56.5%) followed by aneuvrysmal cyst (8,5%) and osteoid osteoma (6,5%). For MBT, the mean age was 12,5 years (5-20 years) and the most affected age group was the 11 to 15 year -old -group (59%). Boys were more affected (60.6%), with a preference for the lower limb (57%) followed by the pelvis (15,6%). Osteosarcoma was the most common MBT (60%) followed by Ewing sarcoma (24%). Given their rarity and heterogeneity, the diagnosis of BT is particular in CAA and requires a multidisciplinary approach. The reporting of epidemiological studies remains essential in order to expand our knowledge regarding these uncommon tumors.
- 1 June 2024
- Published by Universa BV in Acta Orthopaedica Belgica
- Vol. 90 (2) , 303-309
Epidemiology of bone tumors in children and adolescents: a retrospective study of 266 patients in the south of Tunisia
Although bone tumors (BT) are relatively uncommon among the human neoplasm, they constitute the most frequent tumors in children and adolescents (CAA). Little information is available about the epidemiologic features of BT in CAA. We aimed to present and discuss epidemiological characteristics of BT in CAA in southern Tunisia, regarding the different histological types. This is a retrospective study including cases of BT in CAA collected in the pathology department at the Habib Bourguiba university hospital over a period of 15 years (2006- 2020). A total of 266 BT was diagnosed in our institution (42,7% among all BT in Southern Tunisia) divided into 200 benign bone tumors (BBT) (75,2%) and 66 malignant bone tumors (MBT) (24,8%). The mean age for all BT was 14,2 years (3-20 years) with male predominance (sex ratio: 1,48). The most common tumor was osteochondroma (42.2%) followed by osteosarcoma (14.6%) and Ewing sarcoma (6.4%). For BBT, the most affected age group was the 16 to 20 year - old - group (50,7%) with a male predominance (59.8%) and a predilection for lower limb (66.8%) then the upper limb (16,8%). Osteochondroma was the most common histological type (56.5%) followed by aneuvrysmal cyst (8,5%) and osteoid osteoma (6,5%). For MBT, the mean age was 12,5 years (5-20 years) and the most affected age group was the 11 to 15 year -old -group (59%). Boys were more affected (60.6%), with a preference for the lower limb (57%) followed by the pelvis (15,6%). Osteosarcoma was the most common MBT (60%) followed by Ewing sarcoma (24%). Given their rarity and heterogeneity, the diagnosis of BT is particular in CAA and requires a multidisciplinary approach. The reporting of epidemiological studies remains essential in order to expand our knowledge regarding these uncommon tumors.
- 6 March 2024
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 32 (5) , 332-335
Pleomorphic carcinoma of the lung revealed by uncommon colonic metastasis: An exceptional case report with literature review
Lung pleomorphic carcinoma is a rare and aggressive cancer that uncommonly metastasizes to the colon and only a few case reports have been published thus far. We present an exceptional case of colon metastasis from lung pleomorphic carcinoma in a 68-year-old man which was revealed by large bowel perforation, and we review the previous three published cases. Metastasis to the bowel from primary lung malignancy often lacks specific symptoms which result in delayed diagnosis. Bowel metastasis is a poor prognostic factor in patients with lung pleomorphic carcinoma, regardless of management strategy.
- 6 March 2024
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 32 (5) , 332-335
Pleomorphic carcinoma of the lung revealed by uncommon colonic metastasis: An exceptional case report with literature review
Lung pleomorphic carcinoma is a rare and aggressive cancer that uncommonly metastasizes to the colon and only a few case reports have been published thus far. We present an exceptional case of colon metastasis from lung pleomorphic carcinoma in a 68-year-old man which was revealed by large bowel perforation, and we review the previous three published cases. Metastasis to the bowel from primary lung malignancy often lacks specific symptoms which result in delayed diagnosis. Bowel metastasis is a poor prognostic factor in patients with lung pleomorphic carcinoma, regardless of management strategy.
- Open Access
- 15 February 2024
- Published by SAGE Publications in Breast Disease
- Vol. 43 (1) , 9-17
Impact of the COVID-19 pandemic on breast cancer pathological stage at diagnosis in Tunisian patients
BACKGROUND: Breast cancer (BC) patients’ diagnosis and management was affected by a global reorganization after the Coronavirus disease 2019 (COVID-19). Our study aimed to assess the impact of the pandemic on the pathological stage of newly diagnosed patients with BC compared to pre-pandemic and to identify predictive factors of tumor advanced stage. METHODS: Pathological records of all consecutive newly operated BC patients between March 2020 and December 2021 were reviewed retrospectively. Clinical and pathological prognostic factors of BC were collected and compared between pre-pandemic and pandemic periods. Then, predictive factors of tumor advanced stage were identified. RESULTS: Of the 225 cases included in the analysis, 98.7% were females and 1.3% were males. The median time from first histological diagnosis to first surgical treatment was enlarged by 42 days with a significant difference between the two periods (p = 0.002). Newly diagnosed BC patients during the COVID-19 pandemic were operated at a more advanced stage (54.1% vs 36.2%, p = 0.007), had a greater lymphovascular invasion (p = 0.002), lymph node metastasis (p = 0.015) and are more commonly of IBC NST histological type (p = 0.005). Moreover, multivariate analyses showed that the pandemic period (AOR = 2.28; p = 0.016) and the lympho-vascular invasion (p < 0.001) were independently associated with advanced stage of tumors. CONCLUSION: Our findings proved an increase in alarming rates of advanced stage BC associated with the COVID-19 crisis. These findings support recommendations for a quick restoration of BC screening at full capacity, with adequate prioritization strategies to mitigate harm.
- 15 February 2024
- Published by SAGE Publications in Breast Disease
- Vol. 43 (1) , 9-17
Open AccessImpact of the COVID-19 pandemic on breast cancer pathological stage at diagnosis in Tunisian patients
BACKGROUND: Breast cancer (BC) patients’ diagnosis and management was affected by a global reorganization after the Coronavirus disease 2019 (COVID-19). Our study aimed to assess the impact of the pandemic on the pathological stage of newly diagnosed patients with BC compared to pre-pandemic and to identify predictive factors of tumor advanced stage. METHODS: Pathological records of all consecutive newly operated BC patients between March 2020 and December 2021 were reviewed retrospectively. Clinical and pathological prognostic factors of BC were collected and compared between pre-pandemic and pandemic periods. Then, predictive factors of tumor advanced stage were identified. RESULTS: Of the 225 cases included in the analysis, 98.7% were females and 1.3% were males. The median time from first histological diagnosis to first surgical treatment was enlarged by 42 days with a significant difference between the two periods (p = 0.002). Newly diagnosed BC patients during the COVID-19 pandemic were operated at a more advanced stage (54.1% vs 36.2%, p = 0.007), had a greater lymphovascular invasion (p = 0.002), lymph node metastasis (p = 0.015) and are more commonly of IBC NST histological type (p = 0.005). Moreover, multivariate analyses showed that the pandemic period (AOR = 2.28; p = 0.016) and the lympho-vascular invasion (p < 0.001) were independently associated with advanced stage of tumors. CONCLUSION: Our findings proved an increase in alarming rates of advanced stage BC associated with the COVID-19 crisis. These findings support recommendations for a quick restoration of BC screening at full capacity, with adequate prioritization strategies to mitigate harm.
- Open Access
- 24 May 2022
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 42 (70) , 70
Concomitant primary angiosarcoma and invasive carcinoma of the breast: a case report
Collision tumor is a rare entity composed of two different tumors that occur in close to one another and maintain distinct borders. Only few cases have been reported in the breast. We report the first case of concomitant and adjacent primary angiosarcoma (PBAS) and invasive carcinoma of the breast (IBC), in a 45-year-old patient which presented with a lump in her right breast. Biopsy revealed PBAS. She underwent mastectomy. Gross examination showed a hemorrhagic and spongy tumor in contact with a second small grayish-white mass. Histologically, the hemorrhagic tumor was consistent with a high grade (HG) PBAS; the second mass was consistent with an IBC with no images of histological admixture. The diagnosis of a collision tumor composed of HG PBAS and IBC was established. During follow- up, the patient developed ovarian angiosarcomatous metastasis. The diagnosis of breast collision tumor is very uncommon and hence is challenging for pathologist. Careful gross and microscopic examinations help in establishing the appropriate diagnosis.
- 24 May 2022
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 42 (70) , 70
Open AccessConcomitant primary angiosarcoma and invasive carcinoma of the breast: a case report
Collision tumor is a rare entity composed of two different tumors that occur in close to one another and maintain distinct borders. Only few cases have been reported in the breast. We report the first case of concomitant and adjacent primary angiosarcoma (PBAS) and invasive carcinoma of the breast (IBC), in a 45-year-old patient which presented with a lump in her right breast. Biopsy revealed PBAS. She underwent mastectomy. Gross examination showed a hemorrhagic and spongy tumor in contact with a second small grayish-white mass. Histologically, the hemorrhagic tumor was consistent with a high grade (HG) PBAS; the second mass was consistent with an IBC with no images of histological admixture. The diagnosis of a collision tumor composed of HG PBAS and IBC was established. During follow- up, the patient developed ovarian angiosarcomatous metastasis. The diagnosis of breast collision tumor is very uncommon and hence is challenging for pathologist. Careful gross and microscopic examinations help in establishing the appropriate diagnosis.
- 18 May 2022
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 63 (3) , 372-375
Primary cutaneous Rosai–Dorfman–Destombes disease with features mimicking IgG4‐related disease: A challenging case report and literature review
Rosai–Dorfman–Destombes disease (RDD) is a rare histiocytic disorder affecting lymph nodes as well as extranodal sites. Although cutaneous involvement in RDD is common, primary cutaneous RDD is a distinct and not well‐documented entity with unknown aetiology and non‐specific clinicopathological features. We report a case of a 57‐year‐old patient, who presented with an indolent skin nodule in the left sub‐nipple area. Surgical excision was performed. Histological examination concluded to the diagnosis of cutaneous RDD with histological features mimicking IgG4‐related disease. The diagnosis of systemic RDD with cutaneous involvement was ruled out after exclusion of extracutaneous involvement. No recurrence or systemic progression was observed during follow‐up. The diagnosis of primary cutaneous RDD is very uncommon and hence is challenging for pathologist and dermatologist especially with features of IgG4‐related disease. Careful systemic and microscopic examinations help in establishing the appropriate diagnosis.
- 18 May 2022
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 63 (3) , 372-375
Primary cutaneous Rosai–Dorfman–Destombes disease with features mimicking IgG4‐related disease: A challenging case report and literature review
Rosai–Dorfman–Destombes disease (RDD) is a rare histiocytic disorder affecting lymph nodes as well as extranodal sites. Although cutaneous involvement in RDD is common, primary cutaneous RDD is a distinct and not well‐documented entity with unknown aetiology and non‐specific clinicopathological features. We report a case of a 57‐year‐old patient, who presented with an indolent skin nodule in the left sub‐nipple area. Surgical excision was performed. Histological examination concluded to the diagnosis of cutaneous RDD with histological features mimicking IgG4‐related disease. The diagnosis of systemic RDD with cutaneous involvement was ruled out after exclusion of extracutaneous involvement. No recurrence or systemic progression was observed during follow‐up. The diagnosis of primary cutaneous RDD is very uncommon and hence is challenging for pathologist and dermatologist especially with features of IgG4‐related disease. Careful systemic and microscopic examinations help in establishing the appropriate diagnosis.
- Open Access
- 18 April 2022
- Published by Elsevier in Radiology Case Reports
- Vol. 17 (6) , 2186-2190
Primary adult unilateral thalamic pilocytic astrocytoma with von Recklinghausen's disease mimicking lymphoma: A case report
- 18 April 2022
- Published by Elsevier in Radiology Case Reports
- Vol. 17 (6) , 2186-2190
Open AccessPrimary adult unilateral thalamic pilocytic astrocytoma with von Recklinghausen's disease mimicking lymphoma: A case report
- Open Access
- 1 January 2022
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 41 (56) , 56
Liver injury in COVID-19: pathological findings
Hepatic injuries have been reported in patients with Coronavirus disease 2019 infection, particularly in those with moderate to severe illness. To date, pathological changes caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in liver tissue are unclear. Moreover, the mechanisms involved in liver injury in Coronavirus disease 2019 infection are not yet established. In this paper, we summarize the spectrum of pathologic findings of liver injury in patients infected by SARS-CoV-2 and we discuss the clinicopathological correlation and the mechanisms of liver damage in Coronavirus disease 2019 infection.
- 1 January 2022
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 41 (56) , 56
Open AccessLiver injury in COVID-19: pathological findings
Hepatic injuries have been reported in patients with Coronavirus disease 2019 infection, particularly in those with moderate to severe illness. To date, pathological changes caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in liver tissue are unclear. Moreover, the mechanisms involved in liver injury in Coronavirus disease 2019 infection are not yet established. In this paper, we summarize the spectrum of pathologic findings of liver injury in patients infected by SARS-CoV-2 and we discuss the clinicopathological correlation and the mechanisms of liver damage in Coronavirus disease 2019 infection.